APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Artificial Intelligence in Epidemiology

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Artificial Intelligence in Epidemiology Industry Growth and Trends Forecast to 2032

Report ID 17406997014 January 2026123 pages

Choose your research edition.

Industry ResearchArtificial Intelligence in Epidemiology Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Intelligence in Epidemiology Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Artificial Intelligence in Epidemiology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Intelligence in Epidemiology Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Intelligence in Epidemiology Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

According to APO Research, the global Artificial Intelligence in Epidemiology market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Artificial Intelligence in Epidemiology is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Artificial Intelligence in Epidemiology is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Artificial Intelligence in Epidemiology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Artificial Intelligence in Epidemiology market include Abbott Informatics, AdvancedMD, Agilent Technologies, Allscripts Healthcare, Athenahealth, Autoscribe Informatics, Cerner Corporation, Change Healthcare and Cognizant, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Artificial Intelligence in Epidemiology market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Artificial Intelligence in Epidemiology market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Artificial Intelligence in Epidemiology market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Artificial Intelligence in Epidemiology.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Artificial Intelligence in Epidemiology market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Artificial Intelligence in Epidemiology Market by Company

Abbott Informatics

AdvancedMD

Agilent Technologies

Allscripts Healthcare

Athenahealth

Autoscribe Informatics

Cerner Corporation

Change Healthcare

Cognizant

CPSI

CureMD Healthcare

eClinicalWorks

e-Mds Inc.

Epic Systems

GE Healthcare

Google

Graphcore

Greenway Health

IBM

Intel

InterSystems

Kareo

Medhost

Meditech

Medtronic

Micron Technology

Microsoft

NextGen Healthcare

Nvidia

Optum Inc.

Artificial Intelligence in Epidemiology Segment by Type

Hardware Technology

Software Technology

Artificial Intelligence in Epidemiology Segment by Application

Disease and Syndromic Surveillance

Infection Prediction and Forecasting

Immunization Information Systems

Public Sentiment Analysis

Environmental Impact Analysis

Drug Discovery, Safety, and Risk Analysis

Monitoring Population and Incidence

Knowledge Representation and Mass Notification

Artificial Intelligence in Epidemiology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Intelligence in Epidemiology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Intelligence in Epidemiology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Intelligence in Epidemiology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Artificial Intelligence in Epidemiology companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Artificial Intelligence in Epidemiology Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Artificial Intelligence in Epidemiology Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Artificial Intelligence in Epidemiology Market Share by Region (2021-2026) Table 4. Global Artificial Intelligence in Epidemiology Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Artificial Intelligence in Epidemiology Market Share by Region (2027-2032) Table 6. Global Artificial Intelligence in Epidemiology Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Artificial Intelligence in Epidemiology Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Artificial Intelligence in Epidemiology Market Size Share by Type (2021-2026) Table 9. Global Artificial Intelligence in Epidemiology Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Artificial Intelligence in Epidemiology Market Size Share Forecasted by Type (2027-2032) Table 11. North America Artificial Intelligence in Epidemiology Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Artificial Intelligence in Epidemiology Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Artificial Intelligence in Epidemiology Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Artificial Intelligence in Epidemiology Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Artificial Intelligence in Epidemiology Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Artificial Intelligence in Epidemiology Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Artificial Intelligence in Epidemiology Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Artificial Intelligence in Epidemiology Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Artificial Intelligence in Epidemiology Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Artificial Intelligence in Epidemiology Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Artificial Intelligence in Epidemiology Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Artificial Intelligence in Epidemiology Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Artificial Intelligence in Epidemiology Market Size Share by Application (2021-2026) Table 24. Global Artificial Intelligence in Epidemiology Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Artificial Intelligence in Epidemiology Market Size Share Forecasted by Application (2027-2032) Table 26. North America Artificial Intelligence in Epidemiology Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Artificial Intelligence in Epidemiology Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Artificial Intelligence in Epidemiology Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Artificial Intelligence in Epidemiology Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Artificial Intelligence in Epidemiology Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Artificial Intelligence in Epidemiology Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Artificial Intelligence in Epidemiology Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Artificial Intelligence in Epidemiology Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Artificial Intelligence in Epidemiology Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Artificial Intelligence in Epidemiology Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Artificial Intelligence in Epidemiology Industry Trends Table 37. Artificial Intelligence in Epidemiology Industry Drivers Table 38. Artificial Intelligence in Epidemiology Industry Opportunities and Challenges Table 39. Artificial Intelligence in Epidemiology Industry Restraints Table 40. Global Artificial Intelligence in Epidemiology Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Artificial Intelligence in Epidemiology Revenue Market Share by Company (2021-2026) Table 42. Global Artificial Intelligence in Epidemiology Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Artificial Intelligence in Epidemiology Key Company Headquarters & Area Served Table 44. Global Artificial Intelligence in Epidemiology Company, Product Type & Application Table 45. Global Artificial Intelligence in Epidemiology Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Artificial Intelligence in Epidemiology by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Abbott Informatics Company Information Table 49. Abbott Informatics Business Overview Table 50. Abbott Informatics Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Abbott Informatics Artificial Intelligence in Epidemiology Product Portfolio Table 52. Abbott Informatics Recent Development Table 53. AdvancedMD Company Information Table 54. AdvancedMD Business Overview Table 55. AdvancedMD Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. AdvancedMD Artificial Intelligence in Epidemiology Product Portfolio Table 57. AdvancedMD Recent Development Table 58. Agilent Technologies Company Information Table 59. Agilent Technologies Business Overview Table 60. Agilent Technologies Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Agilent Technologies Artificial Intelligence in Epidemiology Product Portfolio Table 62. Agilent Technologies Recent Development Table 63. Allscripts Healthcare Company Information Table 64. Allscripts Healthcare Business Overview Table 65. Allscripts Healthcare Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Allscripts Healthcare Artificial Intelligence in Epidemiology Product Portfolio Table 67. Allscripts Healthcare Recent Development Table 68. Athenahealth Company Information Table 69. Athenahealth Business Overview Table 70. Athenahealth Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Athenahealth Artificial Intelligence in Epidemiology Product Portfolio Table 72. Athenahealth Recent Development Table 73. Autoscribe Informatics Company Information Table 74. Autoscribe Informatics Business Overview Table 75. Autoscribe Informatics Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Autoscribe Informatics Artificial Intelligence in Epidemiology Product Portfolio Table 77. Autoscribe Informatics Recent Development Table 78. Cerner Corporation Company Information Table 79. Cerner Corporation Business Overview Table 80. Cerner Corporation Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Cerner Corporation Artificial Intelligence in Epidemiology Product Portfolio Table 82. Cerner Corporation Recent Development Table 83. Change Healthcare Company Information Table 84. Change Healthcare Business Overview Table 85. Change Healthcare Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Change Healthcare Artificial Intelligence in Epidemiology Product Portfolio Table 87. Change Healthcare Recent Development Table 88. Cognizant Company Information Table 89. Cognizant Business Overview Table 90. Cognizant Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Cognizant Artificial Intelligence in Epidemiology Product Portfolio Table 92. Cognizant Recent Development Table 93. CPSI Company Information Table 94. CPSI Business Overview Table 95. CPSI Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. CPSI Artificial Intelligence in Epidemiology Product Portfolio Table 97. CPSI Recent Development Table 98. CureMD Healthcare Company Information Table 99. CureMD Healthcare Business Overview Table 100. CureMD Healthcare Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. CureMD Healthcare Artificial Intelligence in Epidemiology Product Portfolio Table 102. CureMD Healthcare Recent Development Table 103. eClinicalWorks Company Information Table 104. eClinicalWorks Business Overview Table 105. eClinicalWorks Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. eClinicalWorks Artificial Intelligence in Epidemiology Product Portfolio Table 107. eClinicalWorks Recent Development Table 108. e-Mds Inc. Company Information Table 109. e-Mds Inc. Business Overview Table 110. e-Mds Inc. Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. e-Mds Inc. Artificial Intelligence in Epidemiology Product Portfolio Table 112. e-Mds Inc. Recent Development Table 113. Epic Systems Company Information Table 114. Epic Systems Business Overview Table 115. Epic Systems Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Epic Systems Artificial Intelligence in Epidemiology Product Portfolio Table 117. Epic Systems Recent Development Table 118. GE Healthcare Company Information Table 119. GE Healthcare Business Overview Table 120. GE Healthcare Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. GE Healthcare Artificial Intelligence in Epidemiology Product Portfolio Table 122. GE Healthcare Recent Development Table 123. Google Company Information Table 124. Google Business Overview Table 125. Google Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Google Artificial Intelligence in Epidemiology Product Portfolio Table 127. Google Recent Development Table 128. Graphcore Company Information Table 129. Graphcore Business Overview Table 130. Graphcore Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Graphcore Artificial Intelligence in Epidemiology Product Portfolio Table 132. Graphcore Recent Development Table 133. Greenway Health Company Information Table 134. Greenway Health Business Overview Table 135. Greenway Health Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Greenway Health Artificial Intelligence in Epidemiology Product Portfolio Table 137. Greenway Health Recent Development Table 138. IBM Company Information Table 139. IBM Business Overview Table 140. IBM Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. IBM Artificial Intelligence in Epidemiology Product Portfolio Table 142. IBM Recent Development Table 143. Intel Company Information Table 144. Intel Business Overview Table 145. Intel Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Intel Artificial Intelligence in Epidemiology Product Portfolio Table 147. Intel Recent Development Table 148. InterSystems Company Information Table 149. InterSystems Business Overview Table 150. InterSystems Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. InterSystems Artificial Intelligence in Epidemiology Product Portfolio Table 152. InterSystems Recent Development Table 153. Kareo Company Information Table 154. Kareo Business Overview Table 155. Kareo Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. Kareo Artificial Intelligence in Epidemiology Product Portfolio Table 157. Kareo Recent Development Table 158. Medhost Company Information Table 159. Medhost Business Overview Table 160. Medhost Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Medhost Artificial Intelligence in Epidemiology Product Portfolio Table 162. Medhost Recent Development Table 163. Meditech Company Information Table 164. Meditech Business Overview Table 165. Meditech Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. Meditech Artificial Intelligence in Epidemiology Product Portfolio Table 167. Meditech Recent Development Table 168. Medtronic Company Information Table 169. Medtronic Business Overview Table 170. Medtronic Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 171. Medtronic Artificial Intelligence in Epidemiology Product Portfolio Table 172. Medtronic Recent Development Table 173. Micron Technology Company Information Table 174. Micron Technology Business Overview Table 175. Micron Technology Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 176. Micron Technology Artificial Intelligence in Epidemiology Product Portfolio Table 177. Micron Technology Recent Development Table 178. Microsoft Company Information Table 179. Microsoft Business Overview Table 180. Microsoft Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 181. Microsoft Artificial Intelligence in Epidemiology Product Portfolio Table 182. Microsoft Recent Development Table 183. NextGen Healthcare Company Information Table 184. NextGen Healthcare Business Overview Table 185. NextGen Healthcare Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 186. NextGen Healthcare Artificial Intelligence in Epidemiology Product Portfolio Table 187. NextGen Healthcare Recent Development Table 188. Nvidia Company Information Table 189. Nvidia Business Overview Table 190. Nvidia Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 191. Nvidia Artificial Intelligence in Epidemiology Product Portfolio Table 192. Nvidia Recent Development Table 193. Optum Inc. Company Information Table 194. Optum Inc. Business Overview Table 195. Optum Inc. Artificial Intelligence in Epidemiology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 196. Optum Inc. Artificial Intelligence in Epidemiology Product Portfolio Table 197. Optum Inc. Recent Development Table 198. North America Artificial Intelligence in Epidemiology Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. North America Artificial Intelligence in Epidemiology Market Size by Country (2021-2026) & (US$ Million) Table 200. North America Artificial Intelligence in Epidemiology Market Share by Country (2021-2026) Table 201. North America Artificial Intelligence in Epidemiology Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. North America Artificial Intelligence in Epidemiology Market Share Forecast by Country (2027-2032) Table 203. Europe Artificial Intelligence in Epidemiology Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 204. Europe Artificial Intelligence in Epidemiology Market Size by Country (2021-2026) & (US$ Million) Table 205. Europe Artificial Intelligence in Epidemiology Market Share by Country (2021-2026) Table 206. Europe Artificial Intelligence in Epidemiology Market Size Forecast by Country (2027-2032) & (US$ Million) Table 207. Europe Artificial Intelligence in Epidemiology Market Share Forecast by Country (2027-2032) Table 208. Asia-Pacific Artificial Intelligence in Epidemiology Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 209. Asia-Pacific Artificial Intelligence in Epidemiology Market Size by Country (2021-2026) & (US$ Million) Table 210. Asia-Pacific Artificial Intelligence in Epidemiology Market Share by Country (2021-2026) Table 211. Asia-Pacific Artificial Intelligence in Epidemiology Market Size Forecast by Country (2027-2032) & (US$ Million) Table 212. Asia-Pacific Artificial Intelligence in Epidemiology Market Share Forecast by Country (2027-2032) Table 213. Latin America Artificial Intelligence in Epidemiology Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 214. Latin America Artificial Intelligence in Epidemiology Market Size by Country (2021-2026) & (US$ Million) Table 215. Latin America Artificial Intelligence in Epidemiology Market Share by Country (2021-2026) Table 216. Latin America Artificial Intelligence in Epidemiology Market Size Forecast by Country (2027-2032) & (US$ Million) Table 217. Latin America Artificial Intelligence in Epidemiology Market Share Forecast by Country (2027-2032) Table 218. Middle East & Africa Artificial Intelligence in Epidemiology Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 219. Middle East & Africa Artificial Intelligence in Epidemiology Market Size by Country (2021-2026) & (US$ Million) Table 220. Middle East & Africa Artificial Intelligence in Epidemiology Market Share by Country (2021-2026) Table 221. Middle East & Africa Artificial Intelligence in Epidemiology Market Size Forecast by Country (2027-2032) & (US$ Million) Table 222. Middle East & Africa Artificial Intelligence in Epidemiology Market Share Forecast by Country (2027-2032) Table 223. Research Programs/Design for This Report Table 224. Authors List of This Report Table 225. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Artificial Intelligence in Epidemiology Product Image Figure 3. Global Artificial Intelligence in Epidemiology Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Artificial Intelligence in Epidemiology Market Size (2021-2032) & (US$ Million) Figure 5. Global Artificial Intelligence in Epidemiology Market Share by Region: 2025 VS 2032 Figure 6. Global Artificial Intelligence in Epidemiology Market Share by Region (2021-2032) Figure 7. North America Artificial Intelligence in Epidemiology Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Artificial Intelligence in Epidemiology Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Artificial Intelligence in Epidemiology Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Artificial Intelligence in Epidemiology Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Artificial Intelligence in Epidemiology Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Hardware Technology Image Figure 13. Global Hardware Technology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Software Technology Image Figure 15. Global Software Technology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Artificial Intelligence in Epidemiology Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Artificial Intelligence in Epidemiology Market Share by Type 2025 VS 2032 Figure 18. North America Artificial Intelligence in Epidemiology Market Size Share by Type (2021-2032) Figure 19. Europe Artificial Intelligence in Epidemiology Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Artificial Intelligence in Epidemiology Market Size Share by Type (2021-2032) Figure 21. Latin America Artificial Intelligence in Epidemiology Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Artificial Intelligence in Epidemiology Market Size Share by Type (2021-2032) Figure 23. Disease and Syndromic Surveillance Image Figure 24. Global Disease and Syndromic Surveillance Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Infection Prediction and Forecasting Image Figure 26. Global Infection Prediction and Forecasting Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Immunization Information Systems Image Figure 28. Global Immunization Information Systems Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Public Sentiment Analysis Image Figure 30. Global Public Sentiment Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Environmental Impact Analysis Image Figure 32. Global Environmental Impact Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Drug Discovery, Safety, and Risk Analysis Image Figure 34. Global Drug Discovery, Safety, and Risk Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Monitoring Population and Incidence Image Figure 36. Global Monitoring Population and Incidence Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Knowledge Representation and Mass Notification Image Figure 38. Global Knowledge Representation and Mass Notification Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Global Artificial Intelligence in Epidemiology Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Artificial Intelligence in Epidemiology Market Share by Application 2025 VS 2032 Figure 41. North America Artificial Intelligence in Epidemiology Market Size Share by Application (2021-2032) Figure 42. Europe Artificial Intelligence in Epidemiology Market Size Share by Application (2021-2032) Figure 43. Asia-Pacific Artificial Intelligence in Epidemiology Market Size Share by Application (2021-2032) Figure 44. Latin America Artificial Intelligence in Epidemiology Market Size Share by Application (2021-2032) Figure 45. Middle East and Africa Artificial Intelligence in Epidemiology Market Size Share by Application (2021-2032) Figure 46. Global Top 5 and 10 Artificial Intelligence in Epidemiology Players Market Share by Revenue in 2025 Figure 47. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 48. North America Artificial Intelligence in Epidemiology Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. North America Artificial Intelligence in Epidemiology Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. North America Artificial Intelligence in Epidemiology Market Share by Country (2021-2032) Figure 51. Europe Artificial Intelligence in Epidemiology Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Artificial Intelligence in Epidemiology Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Artificial Intelligence in Epidemiology Market Share by Country (2021-2032) Figure 54. Asia-Pacific Artificial Intelligence in Epidemiology Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Asia-Pacific Artificial Intelligence in Epidemiology Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Asia-Pacific Artificial Intelligence in Epidemiology Market Share by Country (2021-2032) Figure 57. Latin America Artificial Intelligence in Epidemiology Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Artificial Intelligence in Epidemiology Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Artificial Intelligence in Epidemiology Market Share by Country (2021-2032) Figure 60. Middle East & Africa Artificial Intelligence in Epidemiology Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Middle East & Africa Artificial Intelligence in Epidemiology Market Share by Country: 2021 VS 2025 VS 2032 Figure 62. Middle East & Africa Artificial Intelligence in Epidemiology Market Share by Country (2021-2032) Figure 63. Years Considered Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Hardware Technology
  • Software Technology
Applications
  • Disease and Syndromic Surveillance
  • Infection Prediction and Forecasting
  • Immunization Information Systems
  • Public Sentiment Analysis
  • Environmental Impact Analysis
  • Drug Discovery, Safety, and Risk Analysis
  • Monitoring Population and Incidence
  • Knowledge Representation and Mass Notification
Companies covered
  • Abbott Informatics
  • AdvancedMD
  • Agilent Technologies
  • Allscripts Healthcare
  • Athenahealth
  • Autoscribe Informatics
  • Cerner Corporation
  • Change Healthcare
  • Cognizant
  • CPSI
  • CureMD Healthcare
  • eClinicalWorks
  • e-Mds Inc.
  • Epic Systems
  • GE Healthcare
  • Google
  • Graphcore
  • Greenway Health
  • IBM
  • Intel
  • InterSystems
  • Kareo
  • Medhost
  • Meditech
  • Medtronic
  • Micron Technology
  • Microsoft
  • NextGen Healthcare
  • Nvidia
  • Optum Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Artificial Intelligence in Epidemiology Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Artificial Intelligence in Epidemiology Market Size by Region (2021-2032)
  5. 1.4.1 Global Artificial Intelligence in Epidemiology Market Size by Region (2021-2026)
  6. 1.4.2 Global Artificial Intelligence in Epidemiology Market Size by Region (2027-2032)
  7. 1.5 Key Regions Artificial Intelligence in Epidemiology Market Size (2021-2032)
  8. 1.5.1 North America Artificial Intelligence in Epidemiology Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Artificial Intelligence in Epidemiology Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Artificial Intelligence in Epidemiology Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Artificial Intelligence in Epidemiology Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Artificial Intelligence in Epidemiology Market Size Growth Rate (2021-2032)
2 Artificial Intelligence in Epidemiology Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Hardware Technology
  3. 2.1.2 Software Technology
  4. 2.2 Global Artificial Intelligence in Epidemiology Market Size by Type
  5. 2.2.1 Global Artificial Intelligence in Epidemiology Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Artificial Intelligence in Epidemiology Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Artificial Intelligence in Epidemiology Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Artificial Intelligence in Epidemiology Market Size by Regions
  9. 2.3.1 North America Artificial Intelligence in Epidemiology Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Artificial Intelligence in Epidemiology Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Artificial Intelligence in Epidemiology Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Artificial Intelligence in Epidemiology Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Artificial Intelligence in Epidemiology Market Size Breakdown by Type (2021-2026)
3 Artificial Intelligence in Epidemiology Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Disease and Syndromic Surveillance
  3. 3.1.2 Infection Prediction and Forecasting
  4. 3.1.3 Immunization Information Systems
  5. 3.1.4 Public Sentiment Analysis
  6. 3.1.5 Environmental Impact Analysis
  7. 3.1.6 Drug Discovery, Safety, and Risk Analysis
  8. 3.1.7 Monitoring Population and Incidence
  9. 3.1.8 Knowledge Representation and Mass Notification
  10. 3.2 Global Artificial Intelligence in Epidemiology Market Size by Application
  11. 3.2.1 Global Artificial Intelligence in Epidemiology Market Size Overview by Application (2021-2032)
  12. 3.2.2 Global Artificial Intelligence in Epidemiology Historic Market Size Review by Application (2021-2026)
  13. 3.2.3 Global Artificial Intelligence in Epidemiology Market Size Forecasted by Application (2027-2032)
  14. 3.3 Global Artificial Intelligence in Epidemiology Market Size by Regions
  15. 3.3.1 North America Artificial Intelligence in Epidemiology Market Size Breakdown by Application (2021-2026)
  16. 3.3.2 Europe Artificial Intelligence in Epidemiology Market Size Breakdown by Application (2021-2026)
  17. 3.3.3 Asia-Pacific Artificial Intelligence in Epidemiology Market Size Breakdown by Application (2021-2026)
  18. 3.3.4 South America Artificial Intelligence in Epidemiology Market Size Breakdown by Application (2021-2026)
  19. 3.3.5 Middle East and Africa Artificial Intelligence in Epidemiology Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Artificial Intelligence in Epidemiology Industry Trends
  2. 4.2 Artificial Intelligence in Epidemiology Industry Drivers
  3. 4.3 Artificial Intelligence in Epidemiology Industry Opportunities and Challenges
  4. 4.4 Artificial Intelligence in Epidemiology Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Artificial Intelligence in Epidemiology Revenue (2021-2026)
  2. 5.2 Global Artificial Intelligence in Epidemiology Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Artificial Intelligence in Epidemiology Key Company Headquarters & Area Served
  4. 5.4 Global Artificial Intelligence in Epidemiology Company, Product Type & Application
  5. 5.5 Global Artificial Intelligence in Epidemiology Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Artificial Intelligence in Epidemiology Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Artificial Intelligence in Epidemiology Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Artificial Intelligence in Epidemiology Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Abbott Informatics
  2. 6.1.1 Abbott Informatics Company Information
  3. 6.1.2 Abbott Informatics Business Overview
  4. 6.1.3 Abbott Informatics Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Informatics Artificial Intelligence in Epidemiology Product Portfolio
  6. 6.1.5 Abbott Informatics Recent Developments
  7. 6.2 AdvancedMD
  8. 6.2.1 AdvancedMD Company Information
  9. 6.2.2 AdvancedMD Business Overview
  10. 6.2.3 AdvancedMD Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 AdvancedMD Artificial Intelligence in Epidemiology Product Portfolio
  12. 6.2.5 AdvancedMD Recent Developments
  13. 6.3 Agilent Technologies
  14. 6.3.1 Agilent Technologies Company Information
  15. 6.3.2 Agilent Technologies Business Overview
  16. 6.3.3 Agilent Technologies Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Agilent Technologies Artificial Intelligence in Epidemiology Product Portfolio
  18. 6.3.5 Agilent Technologies Recent Developments
  19. 6.4 Allscripts Healthcare
  20. 6.4.1 Allscripts Healthcare Company Information
  21. 6.4.2 Allscripts Healthcare Business Overview
  22. 6.4.3 Allscripts Healthcare Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Allscripts Healthcare Artificial Intelligence in Epidemiology Product Portfolio
  24. 6.4.5 Allscripts Healthcare Recent Developments
  25. 6.5 Athenahealth
  26. 6.5.1 Athenahealth Company Information
  27. 6.5.2 Athenahealth Business Overview
  28. 6.5.3 Athenahealth Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Athenahealth Artificial Intelligence in Epidemiology Product Portfolio
  30. 6.5.5 Athenahealth Recent Developments
  31. 6.6 Autoscribe Informatics
  32. 6.6.1 Autoscribe Informatics Company Information
  33. 6.6.2 Autoscribe Informatics Business Overview
  34. 6.6.3 Autoscribe Informatics Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Autoscribe Informatics Artificial Intelligence in Epidemiology Product Portfolio
  36. 6.6.5 Autoscribe Informatics Recent Developments
  37. 6.7 Cerner Corporation
  38. 6.7.1 Cerner Corporation Company Information
  39. 6.7.2 Cerner Corporation Business Overview
  40. 6.7.3 Cerner Corporation Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Cerner Corporation Artificial Intelligence in Epidemiology Product Portfolio
  42. 6.7.5 Cerner Corporation Recent Developments
  43. 6.8 Change Healthcare
  44. 6.8.1 Change Healthcare Company Information
  45. 6.8.2 Change Healthcare Business Overview
  46. 6.8.3 Change Healthcare Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Change Healthcare Artificial Intelligence in Epidemiology Product Portfolio
  48. 6.8.5 Change Healthcare Recent Developments
  49. 6.9 Cognizant
  50. 6.9.1 Cognizant Company Information
  51. 6.9.2 Cognizant Business Overview
  52. 6.9.3 Cognizant Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Cognizant Artificial Intelligence in Epidemiology Product Portfolio
  54. 6.9.5 Cognizant Recent Developments
  55. 6.10 CPSI
  56. 6.10.1 CPSI Company Information
  57. 6.10.2 CPSI Business Overview
  58. 6.10.3 CPSI Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 CPSI Artificial Intelligence in Epidemiology Product Portfolio
  60. 6.10.5 CPSI Recent Developments
  61. 6.11 CureMD Healthcare
  62. 6.11.1 CureMD Healthcare Company Information
  63. 6.11.2 CureMD Healthcare Business Overview
  64. 6.11.3 CureMD Healthcare Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 CureMD Healthcare Artificial Intelligence in Epidemiology Product Portfolio
  66. 6.11.5 CureMD Healthcare Recent Developments
  67. 6.12 eClinicalWorks
  68. 6.12.1 eClinicalWorks Company Information
  69. 6.12.2 eClinicalWorks Business Overview
  70. 6.12.3 eClinicalWorks Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 eClinicalWorks Artificial Intelligence in Epidemiology Product Portfolio
  72. 6.12.5 eClinicalWorks Recent Developments
  73. 6.13 e-Mds Inc.
  74. 6.13.1 e-Mds Inc. Company Information
  75. 6.13.2 e-Mds Inc. Business Overview
  76. 6.13.3 e-Mds Inc. Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 e-Mds Inc. Artificial Intelligence in Epidemiology Product Portfolio
  78. 6.13.5 e-Mds Inc. Recent Developments
  79. 6.14 Epic Systems
  80. 6.14.1 Epic Systems Company Information
  81. 6.14.2 Epic Systems Business Overview
  82. 6.14.3 Epic Systems Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Epic Systems Artificial Intelligence in Epidemiology Product Portfolio
  84. 6.14.5 Epic Systems Recent Developments
  85. 6.15 GE Healthcare
  86. 6.15.1 GE Healthcare Company Information
  87. 6.15.2 GE Healthcare Business Overview
  88. 6.15.3 GE Healthcare Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 GE Healthcare Artificial Intelligence in Epidemiology Product Portfolio
  90. 6.15.5 GE Healthcare Recent Developments
  91. 6.16 Google
  92. 6.16.1 Google Company Information
  93. 6.16.2 Google Business Overview
  94. 6.16.3 Google Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Google Artificial Intelligence in Epidemiology Product Portfolio
  96. 6.16.5 Google Recent Developments
  97. 6.17 Graphcore
  98. 6.17.1 Graphcore Company Information
  99. 6.17.2 Graphcore Business Overview
  100. 6.17.3 Graphcore Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Graphcore Artificial Intelligence in Epidemiology Product Portfolio
  102. 6.17.5 Graphcore Recent Developments
  103. 6.18 Greenway Health
  104. 6.18.1 Greenway Health Company Information
  105. 6.18.2 Greenway Health Business Overview
  106. 6.18.3 Greenway Health Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Greenway Health Artificial Intelligence in Epidemiology Product Portfolio
  108. 6.18.5 Greenway Health Recent Developments
  109. 6.19 IBM
  110. 6.19.1 IBM Company Information
  111. 6.19.2 IBM Business Overview
  112. 6.19.3 IBM Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 IBM Artificial Intelligence in Epidemiology Product Portfolio
  114. 6.19.5 IBM Recent Developments
  115. 6.20 Intel
  116. 6.20.1 Intel Company Information
  117. 6.20.2 Intel Business Overview
  118. 6.20.3 Intel Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Intel Artificial Intelligence in Epidemiology Product Portfolio
  120. 6.20.5 Intel Recent Developments
  121. 6.21 InterSystems
  122. 6.21.1 InterSystems Company Information
  123. 6.21.2 InterSystems Business Overview
  124. 6.21.3 InterSystems Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 InterSystems Artificial Intelligence in Epidemiology Product Portfolio
  126. 6.21.5 InterSystems Recent Developments
  127. 6.22 Kareo
  128. 6.22.1 Kareo Company Information
  129. 6.22.2 Kareo Business Overview
  130. 6.22.3 Kareo Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 Kareo Artificial Intelligence in Epidemiology Product Portfolio
  132. 6.22.5 Kareo Recent Developments
  133. 6.23 Medhost
  134. 6.23.1 Medhost Company Information
  135. 6.23.2 Medhost Business Overview
  136. 6.23.3 Medhost Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Medhost Artificial Intelligence in Epidemiology Product Portfolio
  138. 6.23.5 Medhost Recent Developments
  139. 6.24 Meditech
  140. 6.24.1 Meditech Company Information
  141. 6.24.2 Meditech Business Overview
  142. 6.24.3 Meditech Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 Meditech Artificial Intelligence in Epidemiology Product Portfolio
  144. 6.24.5 Meditech Recent Developments
  145. 6.25 Medtronic
  146. 6.25.1 Medtronic Company Information
  147. 6.25.2 Medtronic Business Overview
  148. 6.25.3 Medtronic Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  149. 6.25.4 Medtronic Artificial Intelligence in Epidemiology Product Portfolio
  150. 6.25.5 Medtronic Recent Developments
  151. 6.26 Micron Technology
  152. 6.26.1 Micron Technology Company Information
  153. 6.26.2 Micron Technology Business Overview
  154. 6.26.3 Micron Technology Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  155. 6.26.4 Micron Technology Artificial Intelligence in Epidemiology Product Portfolio
  156. 6.26.5 Micron Technology Recent Developments
  157. 6.27 Microsoft
  158. 6.27.1 Microsoft Company Information
  159. 6.27.2 Microsoft Business Overview
  160. 6.27.3 Microsoft Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  161. 6.27.4 Microsoft Artificial Intelligence in Epidemiology Product Portfolio
  162. 6.27.5 Microsoft Recent Developments
  163. 6.28 NextGen Healthcare
  164. 6.28.1 NextGen Healthcare Company Information
  165. 6.28.2 NextGen Healthcare Business Overview
  166. 6.28.3 NextGen Healthcare Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  167. 6.28.4 NextGen Healthcare Artificial Intelligence in Epidemiology Product Portfolio
  168. 6.28.5 NextGen Healthcare Recent Developments
  169. 6.29 Nvidia
  170. 6.29.1 Nvidia Company Information
  171. 6.29.2 Nvidia Business Overview
  172. 6.29.3 Nvidia Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  173. 6.29.4 Nvidia Artificial Intelligence in Epidemiology Product Portfolio
  174. 6.29.5 Nvidia Recent Developments
  175. 6.30 Optum Inc.
  176. 6.30.1 Optum Inc. Company Information
  177. 6.30.2 Optum Inc. Business Overview
  178. 6.30.3 Optum Inc. Artificial Intelligence in Epidemiology Revenue, Global Share and Gross Margin (2021-2026)
  179. 6.30.4 Optum Inc. Artificial Intelligence in Epidemiology Product Portfolio
  180. 6.30.5 Optum Inc. Recent Developments
7 North America
  1. 7.1 North America Artificial Intelligence in Epidemiology Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Artificial Intelligence in Epidemiology Market Size by Country (2021-2026)
  3. 7.3 North America Artificial Intelligence in Epidemiology Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Artificial Intelligence in Epidemiology Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Artificial Intelligence in Epidemiology Market Size by Country (2021-2026)
  3. 8.3 Europe Artificial Intelligence in Epidemiology Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Artificial Intelligence in Epidemiology Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Artificial Intelligence in Epidemiology Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Artificial Intelligence in Epidemiology Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Artificial Intelligence in Epidemiology Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Artificial Intelligence in Epidemiology Market Size by Country (2021-2026)
  3. 10.3 South America Artificial Intelligence in Epidemiology Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Artificial Intelligence in Epidemiology Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Artificial Intelligence in Epidemiology Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Artificial Intelligence in Epidemiology Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst